Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Vu Bartholdy

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Social Psychiatry and Psychiatric Epidemiology|March 21, 2023
Changing prescribing practice for rapid tranquillization-a quality improvement project based on the Plan-Do-Study-Act methodLone Baandrup, Anne Mette Dons, Katja Vu Bartholdy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2026
Left ventricular remodeling and diastolic dysfunction predict cognitive decline in older adultsArshama Dehghan, Fernando R Giugni, Katja Vu Bartholdy, et al.
Kidney360|January 17, 2023
Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD TrialKatja Vu Bartholdy, Niklas Dyrby Johansen, Nino Landler, et al.
Journal of the American College of Cardiology|September 1, 2024
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1Katja Vu Bartholdy, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
NEJM Evidence|October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney DiseaseKatja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Journal of the American College of Cardiology|November 26, 2025
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 TrialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
European Journal of Preventive Cardiology|April 30, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trialLisa Steen Duus, Mats C H Lassen, Niklas D Johansen, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Social Psychiatry and Psychiatric Epidemiology|March 21, 2023
Changing prescribing practice for rapid tranquillization-a quality improvement project based on the Plan-Do-Study-Act methodLone Baandrup, Anne Mette Dons, Katja Vu Bartholdy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2026
Left ventricular remodeling and diastolic dysfunction predict cognitive decline in older adultsArshama Dehghan, Fernando R Giugni, Katja Vu Bartholdy, et al.
Kidney360|January 17, 2023
Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD TrialKatja Vu Bartholdy, Niklas Dyrby Johansen, Nino Landler, et al.
Journal of the American College of Cardiology|September 1, 2024
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1Katja Vu Bartholdy, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
NEJM Evidence|October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney DiseaseKatja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Journal of the American College of Cardiology|November 26, 2025
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 TrialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
European Journal of Preventive Cardiology|April 30, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trialLisa Steen Duus, Mats C H Lassen, Niklas D Johansen, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 2